Long-term Safety of Once-daily Hydrocodone Bitartrate (HYD) Tablets For Moderate to Severe Chronic Nonmalignant and Nonneuropathic Pain. Includes a 24-week Extension Period.
Clinical trial NCT01400139 · COMPLETED
Trial details
- NCT number
- NCT01400139
- Sponsor
- Purdue Pharma LP
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-01
- Primary completion
- 2013-08-01
- Enrollment
- 922
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.